STOCK TITAN

Kura Oncology officer proposes roughly $26K share sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Kura Oncology, Inc. officer Kathleen Ford reported a proposed sale of 3,668 common shares, with an approximate market value of $26,006.12 and an approximate sale date of November 17, 2026. Ford acquired the shares from the issuer as performance stock units on November 13, 2026.

During the prior three months, Ford reported sales of 7,042 shares for gross proceeds of $52,421.35 on November 16, 2026; 3,668 shares for $39,436.87 on September 29, 2026, listed as a 10b5-1 sale; and 6,906 shares for $72,494.35 on September 27, 2026. The reported Rule 10b5-1 plan adoption or instruction date is May 29, 2026.

Proposed shares 3,668 shares Approximate sale date November 17, 2026
Approximate aggregate market value $26,006.12 For the 3,668 common shares proposed for sale
Prior sale 7,042 shares Sold November 16, 2026
Gross proceeds $52,421.35 Sale on November 16, 2026
Prior 10b5-1 sale 3,668 shares Sold September 29, 2026
Gross proceeds $39,436.87 Sale on September 29, 2026
Prior sale 6,906 shares Sold September 27, 2026
Gross proceeds $72,494.35 Sale on September 27, 2026
Performance Stock Units financial
"acquired as Performance Stock Units"
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
Rule 10b5-1 regulatory
"Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many KURA shares is Kathleen Ford proposing to sell?

Kathleen Ford, an officer of Kura Oncology, reported a proposed sale of 3,668 common shares, with an approximate market value of $26,006.12 and an approximate sale date of November 17, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading